Showing results (241-250 of 373) with videos related to
Sort By:
Pageof 38
BMC Cancer|June 30, 2009
Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapyHyo Song Kim, Jeeyun Lee, Seong Yoon Yi, et al.Plos One|August 15, 2014
CDK4 amplification predicts recurrence of well-differentiated liposarcoma of the abdomenSanghoon Lee, Hyojun Park, Sang Yun Ha, et al.Human Pathology|January 17, 2012
The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic casesSeung Eun Lee, Eun Hee Lee, Heejung Park, et al.Cancer Research and Treatment|September 27, 2022
Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment ResponseJung Yong Hong, Hee Jin Cho, Kum-Hee Yun, et al.Korean Journal of Pathology|July 12, 2014
Extrapulmonary lymphangioleiomyoma: clinicopathological analysis of 4 casesDae Hyun Song, In Ho Choi, Sang Yun Ha, et al.Oncology Reports|May 23, 2012
CC chemokine ligand 7 expression in liver metastasis of colorectal cancerYong Beom Cho, Woo Yong Lee, So-Jung Choi, et al.Journal of Pathology and Translational Medicine|May 24, 2017
Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel TestsJihun Kim, Woong-Yang Park, Nayoung K D Kim, et al.Cancer Research and Treatment|February 27, 2015
SEC31A-ALK Fusion Gene in Lung AdenocarcinomaRyong Nam Kim, Yoon-La Choi, Mi-Sook Lee, et al.Oncotarget|September 24, 2015
Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancerYeon Hee Park, Hyun-Tae Shin, Hae Hyun Jung, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2018
Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLCKa-Won Noh, Insuk Sohn, Ji-Young Song, et al.Pageof 38